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Abstract
Objective To investigate the cost effectiveness of joint crisis
plans, a form of advance agreement for people with severe
mental illness.
Design Single blind randomised controlled trial.
Setting Eight community mental health teams in southern
England.
Participants 160 people with a diagnosis of psychotic illness or
non-psychotic bipolar disorder who had been admitted to
hospital at least once within the previous two years.
Intervention Joint crisis plan formulated by the patient, care
coordinator, psychiatrist, and project worker containing contact
information, details of illnesses, treatments, relapse indicators,
and advance statements of preferences for care for future
relapses. Control group was standardised service information.
Main outcome measures Admission to hospital; service use
over 15 months.
Results Use of a joint crisis plan was associated with less service
use and lower costs on average than in the standardised service
information group, but differences were not significant. Total
costs during follow-up were £7264 (€10 616, $13 560) for each
participant with a joint crisis plan and £8359 (€12 217,
$15 609) for each participant with standardised service
information (mean difference £1095; 95% confidence interval
− 2814 to 5004). Cost effectiveness acceptability curves, used to
explore uncertainty in estimates of costs and effects, suggest
there is a greater than 78% probability that joint crisis plans are
more cost effective than standardised service information in
reducing the proportion of patients admitted to hospital.
Conclusion Joint crisis plans produced a non-significant
decrease in admissions and total costs. Though the cost
estimates had wide confidence intervals, the associated
uncertainty suggests there is a relatively high probability of the
plans being more cost effective than standardised service
information for people with psychotic disorders.
Introduction
Many people with a diagnosis of a psychotic disorder have high
rates of relapse, which may result in numerous admissions to
inpatient psychiatric units. This can be distressing for the
individuals concerned as well as costly for society. In 1998 Patel
and Knapp calculated the annual cost to the UK National Health
Service (NHS) of inpatient and residential provision for
schizophrenia and other non-organic psychoses as £946m
(€1382m, $1766m).1 Morris et al and Rice andMiller showed that
79% of direct costs are incurred by only 10% of patients.2 3
The rationale for the joint crisis plan has been previously
reported.4 5 Briefly, these plans aim to mitigate some of the nega-
tive consequences of relapse, including admission to hospital, use
of coercion in the form of the Mental Health Act, and associated
costs. The plan establishes the preferences for treatment of those
who use the service at a point when they are relatively well, to be
applied in any subsequent crisis when the individual may be too
unwell to indicate their preferences. The aim is to reach
agreement between the service user and clinical team through
negotiation and consensus building, facilitated by a third party.
A randomised controlled trial comparing joint crisis plans
with a control intervention in which patients were supplied with
information leaflets relevant to their mental health care
(standardised service information) showed fewer admissions at a
borderline level of significance and significantly reduced use of
the Mental Health Act in the joint crisis plan group.4 We are
reporting the results of the economic evaluation for this trial.
Methods
Our primary hypothesis was that joint crisis plans in addition to
usual care will be more cost effective than standardised service
information in addition to usual care because of reductions in
admissions to hospital and total treatment costs.
The methods of the trial have been reported elsewhere.4 Par-
ticipants were recruited from seven different community mental
health teams across London and one in Kent. Eligible patients
had a clinical diagnosis of psychotic illness, were not currently
receiving inpatient care, and had experienced an admission in
the previous two years.
Interventions
A facilitator, an experienced mental health professional external
to the teams participating in the trial and not involved in the
participants’ care, coordinated the development of a joint crisis
plan. At an introductory meeting the facilitator explained the
procedure to the participating service user and care coordinator
and discussed possible contents of the plan. The facilitator final-
ised the contents at a second meeting with the service user, care
coordinator, and psychiatrist and included contact information,
details of mental and physical illness and their treatment, early
indicators of relapse, and advance statements of preferences for
care in the event of relapse. People specified by the service user,
typically key local services and named friends and family mem-
bers, received a copy of the plan.
Members of the standardised service information control
group received information leaflets on different types of mental
illness and medication, local services, the Mental Health Act,
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complaints procedures, and access to case records, in addition to
receiving treatment as usual.
Outcomes
We assessed outcomes at 15 months after trial entry. These
included admission to hospital, length of time spent in hospital
(primary outcome measures4), and objective coercion (compul-
sory treatment under the Mental Health Act 1983).
Costs
We assessed costs from the perspective of service providers,
including the NHS, social services, and the criminal justice
system.We also considered the perspectives of the user and carer
in terms of out of pocket expenses. We collected data on use of
services from interviews with patients using a modified version
of the client service receipt inventory.6 This was supplemented by
data on hospital admission, bed days, and use of the Mental
Health Act from computerised hospital clinical activity systems
and Mental Health Act office records.
All costs were calculated for the 2000-1 financial year.
Because of lack of data on the timing of resources used, we could
not discount costs that occurred after the first 12 months of the
trial. Given that the data covered 15 months, it is unlikely that the
lack of discounting for costs occurring over a three month
period would significantly affect the results reported.
We costed the joint crisis plan on the basis of the time spent
by the facilitator and clinical teams in producing the crisis plans,
plus relevant administrative, managerial, and capital overheads.
The cost of the control group intervention was calculated on the
basis of the actual purchase cost of the information leaflets with
the cost of the facilitator’s time in distributing them.
We derived unit costs from published cost templates7 to cost
the administration of the Mental Health Act, including initial
assessment, managers’ hearings and tribunal hearings, report
preparation, legal aid provision, and administration. We costed
secondary healthcare services using NHS reference costs8 and
information provided by the South London and Maudsley NHS
Trust finance department. Published unit costs were applied to
community health and social services,9 prison stays,10 medica-
tions,11 and criminal justice resources (contact with lawyers, pro-
bation and police officers, arrests, court appearances, and nights
in police cells).7
As most people with psychotic disorders are unemployed,
changes in productivity are unlikely to be relevant so we did not
measure losses of productivity as a result of time off work due to
illness.
Statistical analyses
Statistical analyses were carried out on an intention to treat basis.
Unit costs were applied to individual service use data and aggre-
gated. Despite the skewed nature of cost data, we analysed differ-
ences in costs between the two groups using the standard t test
and confirmed the validity of results using bootstrapping.12 We
have not reported the bootstrapped results as the confidence
intervals were similar to t test results in all tests. The advantage of
this approach is the ability to make inferences about the
arithmetic mean.13
We assessed cost effectiveness by calculating incremental cost
effectiveness ratios,14 15 which measure the difference in average
costs between the two trial arms divided by the difference in
average effects. In the primary analysis we explored cost
effectiveness in terms of admissions, the primary outcome of the
clinical trial. While it would have been possible to choose
number of admissions or number of days in hospital, both these
variables were associated with relatively high proportions of zero
responses. Instead, we selected the proportion of patients admit-
ted over the follow-up period as the main measure of outcome.
Comparison of the results using the three different variables
showed similar results, thus supporting the validity of this choice.
In secondary analyses we explored cost effectiveness in terms of
use of the Mental Health Act (proportion of patients experienc-
ing compulsory detention over the follow-up period). However,
the results did not differ from the primary analyses and so we
have not reported them here.
We used repeat re-sampling from the costs and effectiveness
data using non-parametric bootstrapping to generate a distribu-
tion of mean costs and effects for the two treatments.12 These dis-
tributions were used to plot cost effectiveness acceptability
curves, which show the probability that the joint crisis plan is cost
effective compared with standardised service information for a
range of maximum monetary values (ceiling ratios, ) that a deci-
sion maker might be willing to pay for a reduction in the propor-
tion of patients admitted to hospital.16 These acceptability curves
illustrate the uncertainty associated with the estimate of costs
and effects as a result of sampling variation and were developed
as a way of overcoming the statistical difficulties of calculating
confidence intervals around incremental cost effectiveness
ratios.17 18 We performed several one way sensitivity analyses to
ascertain thresholds for cost effectiveness and to explore the
robustness of results to changes in the cost data.
Results
Patients
We assessed 466 patients for eligibility. Twenty three did not meet
the criteria for inclusion. Of the remainder, 283 patients were
either not contacted or contacted and declined to take part. The
160 patients remaining were individually randomised to each
arm, and we collected the economic data over a period of 15
months.
Outcomes
Use of the Mental Health Act was significantly reduced in the
joint crisis plan group, with compulsory admission experienced
by 13% compared with 27% in the standardised service informa-
tion group (risk ratio 0.48, 95% confidence interval 0.24 to 0.95,
P = 0.03). There were also fewer admissions to hospital in the
joint crisis plan group, but this difference was not significant
(30% v 44%; ratio 0.69, 0.45 to 1.04, P = 0.07).
Service use
Table 1 shows the mean number of contacts that patients had
with each service over the 15 month follow-up. Patients with joint
crisis plans had fewer psychiatric admissions and outpatient and
accident and emergency attendances, Mental Health Act
episodes, attendances at a day centre, contacts with social work-
ers, and criminal justice contacts. The control group had fewer
non-psychiatric admissions to hospital, fewer contacts with gen-
eral practitioners and community psychiatric nurses, and used
less specialised accommodation. There were no differences in
the receipt of social security benefits or out of pocket expenses
between the two groups.
Costs
The mean total cost per patient over the 15 month study period
was lower in the joint crisis plan group than in the control group
(£7264 (€10 616, $13 560) v £8359 (€12 217, $15 609),
respectively), but this difference was not significant (mean differ-
ence £1095; 95% confidence interval − 2814 to 5004; P = 0.57)
(table 2). Nor were there any significant differences in cost by
providing sector.
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Sensitivity analysis
Threshold analysis revealed that, on average, an additional
reduction of 14 days in hospital per patient in the joint crisis plan
group would be required before the difference in mean total cost
per patient between the two groups became significant (mean
difference £3381, 95% confidence interval 27 to 6735, P = 0.05).
We varied unit costs for bed days, the key cost in this sample, to
explore their impact on the reported results. There was no
impact on the significance of the difference in mean total cost
per patient even when the cost of bed days was halved (£799,
− 1308 to 2906, P = 0.46) or doubled (mean difference £1688,
− 5900 to 9274, P = 0.66). Increasing the cost of the joint crisis
plan intervention to bias the results against the intervention,
even with a fourfold increase in facilitator time, did not alter the
significance of the cost comparison (£963, − 2944 to 4869,
P = 0.63).
Cost effectiveness analysis
The incremental cost effectiveness ratio for admissions over the
15 month follow-up period was − £131 per 1% reduction in the
proportion of patients admitted to hospital. Observed differ-
ences show that the joint crisis plan was cheaper and more effec-
tive on average than standardised service information. Figure 1
shows the cost effectiveness acceptability curve associated with
the proportion of admissions. This shows that the joint crisis
plan is superior to standardised service information over the full
range of values of the ceiling ratio plotted. The curve for the joint
crisis plan shows that there is at least a 78% probability that the
plan is more cost effective than standardised service information
in preventing admissions (range 78% to 94%). Figure 2 shows the
distribution of the bootstrap replicates used to create the cost
effectiveness acceptability curves and illustrates the extent of the
uncertainty. Because a higher effectiveness score is undesirable
(1 = admission, 0 = no admission), moving from left to right on
the x axis means a worsening in the incremental effectiveness for
the joint crisis plan group compared with the control group. This
means that, contrary to conventional economic cost effectiveness
plans, the south west quadrant contains those points where the
experimental intervention is superior to the control
intervention—that is, costs less and is more effective. The scatter
plot clearly shows that most points lie within the desired south
west quadrant, showing strong evidence of differences in costs
and effects in favour of the joint crisis plan group (fig 2).
We re-ran the cost effectiveness acceptability curve analysis
using the cost data from the four sensitivity analyses, described
Table 1 Mean (SD) use of resources over the 15 month follow-up period




Psychiatric inpatient days 32.0 (73.0) 36.0 (69.0)
Psychiatric outpatient attendances 1.5 (2.0) 1.6 (2.0)
Community psychiatric nursing
contacts
185.0 (292.0) 170.0 (292.0)
Psychiatric day service contacts 1.0 (9.0) 1.5 (12.0)
Other community day centre
contacts
5.0 (25.0) 13.0 (38.0)
Mental health act assessments 0.1 (0.4) 0.3 (0.4)
Other health services
Non-psychiatric inpatient days 18.0 (26.0) 2.5 (2.0)
Non-psychiatric outpatient
attendances
18.0 (47.0) 33.0 (89.0)
Accident and emergency contacts
(non-psychiatric)
0.1 (0.2) 0.2 (1.0)
Accident and emergency contacts
(psychiatric)
0.1 (0.4) 0.2 (0.5)
General practitioner contacts 1.9 (4.0) 1.3 (2.0)
No of different medications
prescribed
1.9 (1.8) 1.7 (1.4)
Social services
Social work hours 32.0 (74.0) 138.0 (217.0)
Specialised accommodation weeks 0.3 (0.4) 0.2 (0.4)
Criminal justice
Arrests 0.1 (0.4) 0.2 (0.9)
Contacts with lawyer 0.3 (1.3) 0.3 (1.6)
Court appearances 0.0 (0.2) 0.1 (0.7)
Contacts with probation officer 0 0
Contacts with police officer 0.5 (1.2) 0.7 (1.5)
Nights in police cell 0.1 (0.3) 0.1 (0.4)
Nights in prison 0.2 (1.4) 6.8 (46.0)










Total cost 6064 (12 638) 6912 (12 022) 875 (−2948 to 4698)
JCP/SSI 44 (28) 18 (3) −26 (−32 to −20)
Other health services 1016 (1343) 1033 (1006) 17 (−350 to 385)
Social services 116 (187) 110 (229) −6 (−71 to 59)
Criminal justice sector 37 (138) 274 (1666) 238 (−129 to 604)
Out of pocket expenses:
Patient 14 (36) 7 (20) −6 (−15 to 3)
Carer 18 (61) 22 (99) 4 (−22 to 29)
Total costs 7264 (13 045) 8359 (12 168) 1095 (−2814 to 5004)*
JCP=joint crisis plan; SSI=standardised service information.
*P=0.58.
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Fig 2 Distribution of bootstrap replicates used to create cost effectiveness
acceptability curve (the square represents the incremental cost effectiveness
ratio)
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above, to further explore the effect of such variations. The prob-
ability that joint crisis plans are more cost effective than
standardised service information fell slightly in the analyses
biased against the joint crisis plan intervention but did not fall
below 67% at any point. Increasing facilitator time, and thus
costs, showed the greatest variability with the probability of the
joint crisis plan group being more cost effective than the control
ranging from 67% to 95%.
Discussion
Crisis planning interventions seem to be a cost effective method
of preventing admissions and compulsory treatment for people
with psychotic disorders. In this study there were fewer compul-
sory admissions in the joint crisis plan group than the standard-
ised service information group. Numbers of total admissions and
total costs were also lower in the plan group, but these
differences were not significant. Exploration of the uncertainty
surrounding the estimates of costs and effects suggests that there
is at least a 78% probability that joint crisis plans are a more cost
effective strategy than standardised service information for
reducing the probability of admissions, irrespective of the
amount a decision maker may be willing to pay for such reduc-
tions. Attempts to bias against the intervention in sensitivity
analysis reduced this probability somewhat, but there was still a
minimum probability in favour of joint crisis plans of 67%.
In the long term, joint crisis plans are not particularly
resource intensive; the marginal cost of facilitating an additional
joint crisis plan is relatively small. In the short term, however, the
provision of facilitated plans may involve investment in the sala-
ries of the facilitators. Whether this is affordable must be consid-
ered with evidence of the probable cost effectiveness of joint
crisis plans and any savings made by reducing admissions.
One limitation of the current study was the lack of a measure
of change from the patients’ perspective. It is reasonable to
assume, however, that fewer admissions, particularly compulsory
admissions, would have a positive impact on quality of life. Such
perspectives should be explored in future research of advance
statements.
Our findings are of interest with respect to a new or amended
Mental Health Act in England. A parliamentary committee has
commented that measures proposed by the government could
erode civil liberties and be too heavily focused on compulsion.19
Advance statements in the form of joint crisis plans may have the
potential to reduce both compulsion and costs.
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What is already known on this topic
Joint crisis plans, formulated jointly by a mental health
service user, a clinician, and a facilitator, are highly
acceptable to service users
Such plans have been shown to approximately halve the
use of compulsion during psychiatric hospital admission for
people with psychotic disorders
People with psychotic disorders who create and use plans
may also have modestly reduced hospital admission rates
What this study adds
Over 15 months total costs were £7264 for each person
with a joint crisis plan and £8359 for each person with
standardised service information
Cost effectiveness acceptability curves suggest there is a
greater than 78% probability that joint crisis plans are more
cost effective than standardised service information in
reducing the proportion of patients admitted to hospital
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